Olema Pharmaceuticals faced a 30% stock drop after ESMO 2025 data on palazestrant, its lead breast cancer candidate. Click ...

Recently, there have been concerns around the surge of fraudulent loans and private credit quality issues in the US.

​This partnership builds on an earlier collaboration, which was launched between the two companies in 2022. As part of this ...

Teva Pharmaceutical Industries Ltd. (TEVA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most ...

Fintel reports that on October 21, 2025, Citigroup initiated coverage of ACADIA Pharmaceuticals (NasdaqGS:ACAD) with a Buy ...

These dividend stocks are waiting for growth and income investors to step up to the plate. Plus, they are rated Buy at top ...

An investigational treatment, used in combination with another cancer medication, took an important step forward after ...

Portfolio diversification is also important -- but not too much. But how can you build a Buffett-inspired portfolio for ...

From Ramesh Damani to Atul Suri; Dipan Mehta to Nilesh Shah; Dharmesh Kant to Deven Choksey, here's what these market experts ...

Commission approves acquisition of JB Chemicals & Pharmaceuticals Ltd by Torrent Pharmaceuticals Ltd with voluntary ...

Stocks rallied over 1% as economic expansion & corporate profit growth continue to underpin the bull market. Learn more about ...

For instance, Oncology Institute ( TOI 0.02%), a provider of oncology care, has seen its stock price soar 1,130% through Oct.